Cardinal Health Inc
CAH
ISIN US14149Y1082 / Valor 196652
Cardinal Health Inc
UMushroom community rating:
About company
Cardinal Health Inc. is a prominent global healthcare services and products company, with a focus on providing tailored solutions across various sectors of the healthcare industry. With over 50 years of experience, the company operates as a key distributor of pharmaceuticals and a manufacturer and distributor of medical and laboratory products. Additionally, Cardinal Health offers performance and data solutions to healthcare facilities, aiming to address some of the most complex challenges within the healthcare sector. The company boasts a significant global presence, with approximately 48,000 employees worldwide. Cardinal Health's extensive portfolio serves hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients at home, underscoring its integral role in the healthcare supply chain.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (20.08.2024):
Revenue Growth
Cardinal Health Inc. reported fourth quarter fiscal year 2024 revenues of $59.9 billion, marking a 12% increase from the prior year. This growth was driven by strong performance across its business segments, particularly in Pharmaceutical and Specialty Solutions.
Operating Earnings
For the fourth quarter of fiscal year 2024, Cardinal Health Inc. achieved GAAP operating earnings of $401 million. This represents a significant improvement compared to the previous year's results, reflecting the company's effective cost management and operational efficiencies.
Non-GAAP Earnings
Cardinal Health Inc.'s non-GAAP operating earnings for the fourth quarter of fiscal year 2024 increased by 14% to $605 million. This growth was primarily driven by segment profit increases in Global Medical Products and Distribution (GMPD) and Pharmaceutical and Specialty Solutions.
Annual Financial Performance
For the full fiscal year 2024, Cardinal Health Inc. reported revenues of $226.8 billion, an 11% increase from fiscal year 2023. The company's GAAP operating earnings for the year were $1.2 billion, while non-GAAP operating earnings rose by 16% to $2.4 billion.
Fiscal Year 2025 Guidance
Cardinal Health Inc. has raised its fiscal year 2025 non-GAAP EPS guidance to a range of $7.55 to $7.70, up from the previous guidance of at least $7.50. This optimistic outlook reflects the company's confidence in continued operational improvements and strategic initiatives.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
28637 M
Market cap (USD)
635,357
Daily traded volume (Shares)
120.42 / 118.2
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
